140 related articles for article (PubMed ID: 2887189)
1. Post-exercise hypotension: the effects of epanolol or atenolol on some hormonal and cardiovascular variables in hypertensive men.
Wilcox RG; Bennett T; Macdonald IA; Broughton Pipkin F; Baylis PH
Br J Clin Pharmacol; 1987 Aug; 24(2):151-62. PubMed ID: 2887189
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
3. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
4. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
5. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
Smith SA; Littler WA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
[TBL] [Abstract][Full Text] [Related]
6. Comparison between atenolol and nadolol in essential hypertension at rest and on exercise.
Wilcox RG; Hampton JR
Br J Clin Pharmacol; 1982 Jun; 13(6):841-6. PubMed ID: 6124268
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Simon G; Wittig VJ
J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
9. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
[TBL] [Abstract][Full Text] [Related]
10. Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
Leonetti G; Terzoli L; Bianchini C; Sala C; Zanchetti A
Eur J Clin Pharmacol; 1980 Nov; 18(5):365-74. PubMed ID: 7002567
[TBL] [Abstract][Full Text] [Related]
11. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
12. Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.
Jonsson G; Fossum E; Kjeldsen SE; Høieggen A; Os I; Eide I; Westheim A
Blood Press; 2002; 11(6):377-84. PubMed ID: 12523682
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
Rydén L
J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
[TBL] [Abstract][Full Text] [Related]
14. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
Lefebvre RA; Bogaert MG; Duprez D
Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
[TBL] [Abstract][Full Text] [Related]
15. Home blood pressure monitoring and changes in plasma catecholamines during once or twice daily treatment with atenolol in patients with mild hypertension.
McGrath BP; Beilin LJ; Schofield T; Benedict CR; Barker NP; Cooper R
Aust N Z J Med; 1979 Aug; 9(4):374-81. PubMed ID: 389223
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
Kaiser P; Hylander B; Eliasson K; Kaijser L
Am J Cardiol; 1985 Apr; 55(10):79D-84D. PubMed ID: 3993553
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of atenolol in hypertensive patients.
Ibrahim MM; Mossallam R
Circulation; 1981 Aug; 64(2):368-74. PubMed ID: 7249304
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of exercise tolerance in hypertensive patients treated with atenolol and methyldopa].
Ambrosioni E; Costa FV; Agosta R; Magnani B
G Clin Med; 1979 Aug; 60(8):676-83. PubMed ID: 398306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
